Clinical Pharmacokinetics of Diclofenac
暂无分享,去创建一个
[1] E. Ku,et al. Diclofenac sodium (GP 45840, Voltaren), a potent inhibitor of prostaglandin synthetase. , 1975, Biochemical pharmacology.
[2] F. Michot,et al. A Double-Blind Clinical Trial to Determine if an Interaction Exists between Diclofenac Sodium and the Oral Anticoagulant Acenocoumarol (Nicoumalone) , 1975, The Journal of international medical research.
[3] U. P. Geiger,et al. Quantitative assay of diclofenac in biological material by gas-liquid chromatography. , 1975, Journal of chromatography.
[4] F. Wagenhäuser. Chronic forms of polyarthritis , 1976 .
[5] P. Brombacher,et al. Quantitative determination of sodium-o-[(2,6-dichlorophenyl)-amino]phenylacetate (diclofenac) in human blood plasma or serum. , 1977, Arzneimittel-Forschung.
[6] Müller Fo,et al. Pharmacokinetic and pharmacodynamic implications of long-term administration of non-steroidal anti-inflammatory agents. , 1977 .
[7] M. Kendall,et al. Pharmacokinetic studies on diclofenac sodium in young and old volunteers. , 1978, Scandinavian journal of rheumatology. Supplement.
[8] H. Stierlin,et al. Pharmacokinetics of diclofenac sodium (Voltaren) and metabolites in patients with impaired renal function. , 1978, Scandinavian journal of rheumatology. Supplement.
[9] M. Sulc,et al. Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. , 1978, Scandinavian journal of rheumatology. Supplement.
[10] A. Sallmann,et al. Pharmacological properties of diclofenac sodium and its metabolites. , 1978, Scandinavian journal of rheumatology. Supplement.
[11] W. Richter,et al. Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites. , 1979, Xenobiotica; the fate of foreign compounds in biological systems.
[12] J. Seldrup,et al. The influence of diclofenac sodium (Voltarol) on free, protein-bound and total plasma L-tryptophan in adult healthy male subjects. , 1979, Rheumatology and rehabilitation.
[13] M. Kendall,et al. Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol). , 1979, Rheumatology and rehabilitation.
[14] H. Stierlin,et al. Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. , 1979, Xenobiotica; the fate of foreign compounds in biological systems.
[15] Johnson Va. The pharmacokinetics and metabolism of diclofenac sodium (Voltarol) in animals and man. , 1979, Rheumatology and rehabilitation.
[16] F. Nielsen‐Kudsk. HPLC-determination of some antiinflammatory, weak analgesic and uricosuric drugs in human blood plasma and its application to pharmacokinetics. , 2009, Acta pharmacologica et toxicologica.
[17] M. Kendall,et al. Determination of total monohydroxylated metabolites of diclofenac in urine by electron-capture gas-liquid chromatography. , 1980, Journal of chromatography.
[18] G. Köhler,et al. Zur Kinetik von Diclofenac-NA in Plasma und Synovialflüssigkeit , 1980 .
[19] A. Schumacher,et al. Quantitative Bestimmung von Diclofenac-Natrium aus Plasma durch Absorptionsmessung mit Hilfe der direkten Auswertung von Dünnschichtchromatogrammen , 1980 .
[20] R. Rau,et al. Die Beeinflussung des Digoxinblutspiegels durch Antirheumatika , 1980 .
[21] M. Kawase,et al. Improved gas chromatographic method of determining diclofenac in plasma. , 1980, Journal of chromatography.
[22] Said Sa,et al. Pharmacokinetics of diclofenac sodium using a developed HPLC method. , 1981 .
[23] J. Frölich,et al. Effects of diclofenac on lithium kinetics , 1981, Clinical pharmacology and therapeutics.
[24] P. Degen,et al. Simultaneous determination of diclofenac sodium and its hydroxy metabolites by capillary column gas chromatography with electron-capture detection. , 1981, Journal of chromatography.
[25] Keith K. H. Chan,et al. A Rapid and Sensitive Method for The Determination of Diclofenac Sodium in Plasma By High-Performance Liquid Chromatography , 1982 .
[26] M. Fischer. Beeinflußt Diclofenac die plasmatische Gerinnung bei einer Thromboembolienprophylaxe mit Heparin/Dihydroergotamin? , 1982 .
[27] A. Gaucher,et al. [Transport of sodium diclofenac into synovial fluid]. , 1983, Therapie.
[28] C. Reinicke,et al. Diclofenac-Natrium(Voltaren®) hat keinen Einfluß auf die hepatische Demethylierung von Aminopyrin bei Patienten mit rheumatischen Erkrankungen , 1983 .
[29] A. Schumacher,et al. Untersuchungen potentieller Interaktionen von Diclofenac-Natrium (Voltaren®) mit den Basistherapeutika Gold, D-Penicillamin, Chloroquin, Azathioprin und mit Prednisolon , 1983 .
[30] H. Ylijoki,et al. Treatment of juvenile rheumatoid arthritis with diclofenac sodium. , 1983, Scandinavian journal of rheumatology.
[31] A. Sioufi,et al. Présence du diclofénac dans le plasma et le liquide synovial au cours de diverses affections rhumatismales , 1984 .
[32] H. Kadowaki,et al. Sensitive method for the determination of diclofenac in human plasma by gas chromatography-mass spectrometry. , 1984, Journal of chromatography.
[33] W. Gross,et al. Diclofenac sodium: blood concentration of the slow-release form and influence on the metabolism of kallikrein. , 1984, Arzneimittel-Forschung.
[34] K. Antonin,et al. Colonoscopy in the investigation of drug absorption in healthy volunteers. , 1985, Gastrointestinal endoscopy.
[35] J. Godbillon,et al. High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids. , 1985, Journal of chromatography.
[36] F. Plavšić,et al. Determination of Serum Diclofenac by High-performance Liquid Chromatography by Electromechanical Detection , 1985, Human toxicology.
[37] Keith K. H. Chan,et al. Determination of Diclofenac Sodium in Synovial Fluid by High Performance Liquid Chromatography , 1985 .
[38] K. Brandt,et al. Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis. , 1985, Seminars in arthritis and rheumatism.
[39] H. Battista,et al. Separation and identification of non-steroidal antirheumatic drugs containing a free carboxyl function using high-performance liquid chromatography. , 1985, Journal of chromatography.
[40] B. Terhaag,et al. Zur Beziehung von in-vitro- und in-vivo-Untersuchungen beim Menschen am Beispiel von Diclofenac-Suppositorien , 1985 .
[41] G Houin,et al. Diclofenac binding to albumin and lipoproteins in human serum. , 1985, Biochemical pharmacology.
[42] L. Botta,et al. [The percutaneous absorption of diclofenac]. , 1986, Arzneimittel-Forschung.
[43] S. Ekblom-Kullberg,et al. Drug points: Reversible deterioration of renal function after diclofenac in patient receiving triamterene , 1986 .
[44] Helen Daly,et al. INTERACTION BETWEEN METHOTREXATE AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS , 1986, The Lancet.
[45] A. Gabrielli,et al. Drug points: Methotrexate and non-steroidal anti-inflammatory drugs , 1987 .
[46] M. Roberts,et al. Rapid high-performance liquid chromatographic assay for the simultaneous analysis of non-steroidal antiinflammatory drugs in plasma , 1987 .
[47] A Ward,et al. Pentoxifylline , 1987, Drugs.
[48] K. Brandt,et al. In vitro protein binding of diclofenac sodium in plasma and synovial fluid. , 1987, Journal of pharmaceutical sciences.
[49] Abu-Romeh Sh,et al. Enhancement of cyclosporine A nephrotoxicity by diclofenac. , 1987 .
[50] C. Giachetti,et al. Determination of diclofenac in plasma samples. Comparison between HRGC and HPLC , 1987 .
[51] L. Guillevin,et al. Pharmacokinetics of Paracetamol, Diclofenac and Vidarabine during Plasma Exchange , 1988, The International journal of artificial organs.
[52] P. Meffin,et al. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs? , 1988, The Journal of rheumatology.
[53] T. Winkler,et al. A new metabolite of diclofenac sodium in human plasma. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.
[54] P. Degen,et al. Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.
[55] I. Raz,et al. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects. , 1988, International journal of clinical pharmacology, therapy, and toxicology.
[56] H. Leis,et al. Femtomole analysis of diclofenac in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry using (18O2) diclofenac as internal standard. , 1988, Biomedical & environmental mass spectrometry.
[57] R. de la Torre,et al. Detection and quantification of non-steroidal anti-inflammatory agents by gas chromatography/mass spectrometry: diclofenac. , 1988, Biomedical & environmental mass spectrometry.
[58] Nishihata Toshiaki,et al. Percutaneous absorption of diclofenac in rats and humans: aqueous gel formulation , 1988 .
[59] M. Deakin. Small bowel perforation associated with an excessive dose of slow release diclofenac sodium. , 1988, BMJ.
[60] M. Hasan,et al. Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets. , 1988, International journal of clinical pharmacology, therapy, and toxicology.
[61] Y. El‐Sayed,et al. A rapid and sensitive high‐performance liquid chromatographic method for the determination of diclofenac sodium in serum and its use in pharmacokinetic studies , 1988, The Journal of pharmacy and pharmacology.
[62] J. Walls,et al. Nonsteroidal antiinflammatory drugs and cyclosporine. A potentially serious adverse interaction. , 1988, Transplantation.
[63] D. Grandjean,et al. Automated robotic extraction and subsequent analysis of diclofenac in plasma samples. , 1989, Journal of pharmaceutical sciences.
[64] M. Rongier,et al. Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: application to diclofenac. , 1989, British journal of clinical pharmacology.
[65] L. Zecca,et al. Determination of diclofenac in plasma and synovial fluid by high-performance liquid chromatography with electrochemical detection. , 1989, Journal of Chromatography A.
[66] R. Sheers,et al. NSAIDs AND GUT DAMAGE , 1989, The Lancet.
[67] M. Hasan,et al. A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium. , 1989, International journal of clinical pharmacology, therapy, and toxicology.
[68] H. Mascher. The pharmacokinetics of a new sustained-release form of diclofenac sodium in humans. , 1989, Drug design and delivery.
[69] T. Vree,et al. Pharmacokinetics of rectal diclofenac and its hydroxy metabolites in man. , 1990, International journal of clinical pharmacology, therapy, and toxicology.
[70] T. Vree,et al. High-performance liquid chromatographic method for the determination of diclofenac and its hydroxy metabolites in human plasma and urine. , 1990, Journal of chromatography.
[71] K. Brune,et al. Biliary elimination of non-steroidal anti-inflammatory drugs in patients. , 1990, British journal of clinical pharmacology.
[72] Brown Mj,et al. Colonic ulceration and bleeding during diclofenac therapy. , 1990 .
[73] M. Mustofa,et al. The relative bioavailability of diclofenac with respect to time of administration. , 1991, British journal of clinical pharmacology.
[74] R. Paroni,et al. Determination of diclofenac in human plasma by selected ion monitoring. , 1991, Biological mass spectrometry.
[75] L. A. Brunner,et al. An automated method for the determination of diclofenac sodium in human plasma. , 1991, Journal of chromatographic science.
[76] B. Terhaag,et al. The influence of food on the absorption of diclofenac as a pure substance. , 1991, International journal of clinical pharmacology, therapy, and toxicology.
[77] J. P. Branthwaite,et al. Cyclosporin and diclofenac interaction in rheumatoid arthritis , 1991, The Lancet.
[78] K. Praser. Non-steroidal anti-inflammatory drugs. , 1991, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[79] N. Najib,et al. Comparative bioavailability of two tablet formulations of diclofenac sodium in normal subjects. , 1991, International journal of clinical pharmacology, therapy, and toxicology.
[80] M. Scholl,et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. , 1991, British journal of clinical pharmacology.
[81] L. Guillevin,et al. Diclofenac, paracetamol, and vidarabine removal during plasma exchange in polyarteritis nodosa patients , 1991, Biopharmaceutics & drug disposition.
[82] C. Sahajwalla,et al. Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard. , 1991, The Journal of the Association of Physicians of India.
[83] F. Halter,et al. Nonsteroidal antiinflammatory drug-induced colonic strictures: a case report. , 1991, Gastroenterology.
[84] P. Neuvonen. The effect of magnesium hydroxide on the oral absorption of ibuprofen, ketoprofen and diclofenac. , 1991, British journal of clinical pharmacology.
[85] B. Wiese,et al. Bioanalysis of diclofenac as its fluorescent carbazole acetic acid derivative by a post-column photoderivatization high-performance liquid chromatographic method. , 1991, Journal of chromatography.
[86] L. Zecca,et al. Determination of diclofenac and its metabolites in plasma and cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection. , 1991, Journal of chromatography.
[87] A. Sioufi,et al. Determination of diclofenac in plasma using a fully automated analytical system combining liquid-solid extraction with liquid chromatography. , 1991, Journal of chromatography.
[88] J. Moncrieff. Extractionless determination of diclofenac sodium in serum using reversed-phase high-performance liquid chromatography with fluorimetric detection. , 1992, Journal of chromatography.
[89] M. Doherty,et al. High-performance liquid chromatographic determination of naproxen, ibuprofen and diclofenac in plasma and synovial fluid in man. , 1992, Journal of chromatography.
[90] A. Karim,et al. Biopharmaceutical profile of diclofenac-misoprostol combination tablet, Arthrotec. , 1992, Scandinavian journal of rheumatology. Supplement.
[91] I. Fellows,et al. Non-steroidal anti-inflammatory drug-induced jejunal and colonic diaphragm disease: a report of two cases. , 1992, Gut.
[92] A. West,et al. A cecal diaphragm associated with the use of nonsteroidal anti-inflammatory drugs. , 1992, Journal of clinical gastroenterology.
[93] H. Zachariae. Methotrexate and non‐steroidal anti‐inflammatory drugs , 1992, The British journal of dermatology.
[94] P. Luisi,et al. Lecithin organogel as matrix for transdermal transport of drugs. , 1992, Journal of pharmaceutical sciences.
[95] S. Santos,et al. Simplified micromethod for the HPLC measurement of diclofenac in plasma. , 1992, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[96] J. Castellana,et al. Effect of food and relative bioavailability following single doses of diclofenac 150mg hydrogel bead (HGB) capsules in healthy humans , 1992, Biopharmaceutics & drug disposition.
[97] Seth Bl. Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel. , 1992 .
[98] K. L. Goa,et al. Ocular Diclofenac , 1992, Drugs & aging.
[99] N. Najib,et al. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration. , 1993, International journal of clinical pharmacology, therapy, and toxicology.
[100] J. Keating,et al. Simultaneous small and large bowel ulceration associated with short term NSAID use. , 1993, The New Zealand medical journal.
[101] W. Siegmund,et al. Potential pharmacokinetic interactions of nocloprost clathrate with retarded theophylline and enteric coated diclofenac after single and repeated premedication in healthy volunteers. , 1993, International journal of clinical pharmacology, therapy, and toxicology.
[102] T. Leemann,et al. Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver. , 1993, Life sciences.
[103] G. Schmitz,et al. High-performance liquid chromatographic method for the routine determination of diclofenac and its hydroxy and methoxy metabolites from in vitro systems. , 1993, Journal of chromatography.
[104] S. Malamataris,et al. Extractionless high-performance liquid chromatographic method for the determination of diclofenac in human plasma and urine. , 1993, Journal of chromatography.
[105] C. Giachetti,et al. Local tolerability and pharmacokinetic profile of a new transdermal delivery system, diclofenac hydroxyethylpyrrolidine plaster. , 1993, Drugs under experimental and clinical research.
[106] J. Kovarik,et al. Pharmacokinetics of Cyclosporine and Multiple‐Dose Diclofenac During Coadministration , 1993, Journal of clinical pharmacology.
[107] F. Halter,et al. Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. , 1993, Journal of clinical gastroenterology.
[108] L. Maggi,et al. Pharmacokinetic studies in healthy volunteers on a new gastroprotective pharmaceutic form of diclofenac. , 1993, Arzneimittel-Forschung.
[109] R. Marcolongo,et al. Pharmacokinetics of diclofenac hydroxyethylpyrrolidine (DHEP) plasters in patients with monolateral knee joint effusion. , 1993, Drugs under experimental and clinical research.
[110] M. Roberts,et al. Disappearance kinetics of solutes from synovial fluid after intra-articular injection. , 1994, British journal of clinical pharmacology.
[111] F. Boschet,et al. Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel , 1994, Biopharmaceutics & drug disposition.
[112] M. Kurowski,et al. The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients. , 1994, International journal of clinical pharmacology and therapeutics.
[113] M. Roberts,et al. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. , 1994, The Journal of pharmacology and experimental therapeutics.
[114] M. Riegel,et al. High-performance liquid chromatographic assay for antiinflammatory agents diclofenac and flurbiprofen in ocular fluids. , 1994, Journal of chromatography. B, Biomedical applications.
[115] J. Wallace,et al. Markedly reduced intestinal toxicity of a diclofenac derivative. , 1994, Life sciences.
[116] S. Y. Zhang,et al. [High-performance liquid chromatographic method for the determination of diclofenac in serum and its pharmacokinetics in healthy volunteers]. , 1994, Yao xue xue bao = Acta pharmaceutica Sinica.
[117] S. Umeki. Activation factors of neutrophil NADPH oxidase complex. , 1994, Life sciences.
[118] J. Wallace,et al. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. , 1994, Gastroenterology.
[119] P. Ellis,et al. Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application. , 1994, Journal of ocular pharmacology.
[120] G. De Nucci,et al. Comparative bioavailability of two suspension formulations of potassium diclofenac in healthy male volunteers. , 1994, International journal of clinical pharmacology and therapeutics.
[121] Y. El‐Sayed,et al. The effects of cholestyramine and colestipol on the absorption of diclofenac in man. , 1994, International journal of clinical pharmacology and therapeutics.
[122] J. Meulenbelt,et al. The bioavailability of diclofenac from enteric coated products in healthy volunteers with normal and artificially decreased gastric acidity , 1994, Biopharmaceutics & drug disposition.
[123] W. Baeyens,et al. The determination of non-steroidal antiinflammatory drugs in pharmaceuticals by capillary zone electrophoresis and micellar electrokinetic capillary chromatography. , 1994, Journal of pharmaceutical and biomedical analysis.
[124] J. Wallace,et al. A diclofenac derivative without ulcerogenic properties. , 1994, European journal of pharmacology.
[125] J. Hart,et al. A case of diclofenac-induced colitis with focal granulomatous change. , 1995, The American journal of gastroenterology.
[126] C H Liu,et al. In‐vitro and In‐vivo Studies of the Diclofenac Sodium Controlled‐release Matrix Tablets , 1995, The Journal of pharmacy and pharmacology.
[127] A. Russell,et al. Small bowel permeability--a variable effect of NSAIDS. , 1995, Clinical and investigative medicine. Medecine clinique et experimentale.
[128] D. Friedman,et al. Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs. , 1995, Journal of pharmaceutical sciences.
[129] X. Causse,et al. Nonsteroidal anti-inflammatory drug-induced colonic strictures: two cases and literature review. , 1995, The American journal of gastroenterology.
[130] C. Müller-Goymann,et al. Diclofenac release from phospholipid drug systems and permeation through excised human stratum corneum , 1995 .
[131] R. Grahame. TRANSDERMAL NON‐STEROIDAL ANTI‐INFLAMMATORY AGENTS , 1995, The British journal of clinical practice.
[132] A. Carcas,et al. Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks. , 1995, International journal of clinical pharmacology and therapeutics.
[133] J. Kovarik,et al. Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction. , 1996, The Journal of rheumatology.
[134] P. Diwan,et al. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans. , 1996, Arzneimittel-Forschung.
[135] A. Hanses,et al. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration. , 1996, Arzneimittel-Forschung.
[136] U. Pfaar,et al. Characterization of a novel diclofenac metabolite in human urine by capillary gas chromatography-negative chemical ionization mass spectrometry. , 1996, Journal of chromatography. B, Biomedical applications.
[137] R. Tallarida,et al. The Analgesic Interaction of Misoprostol with Nonsteroidal Anti-Inflammatory Drugs. , 1996, American journal of therapeutics.
[138] M. Borenstein,et al. Sensitive capillary gas chromatographic-mass spectrometric-selected-ion monitoring method for the determination of diclofenac concentrations in human plasma. , 1996, Journal of chromatography. B, Biomedical applications.
[139] N. Davies,et al. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. , 1997, Gastroenterology.
[140] Paul Walther,et al. Interaction of a Lecithin Microemulsion Gel with Human Stratum Corneum and its Effect on Transdermal Transport , 1997 .
[141] M. A. Pierossi,et al. Short-term sucralfate administration alters potassium diclofenac absorption in healthy male volunteers. , 1997, British journal of clinical pharmacology.